Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Fai Ng

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
The Journal of Allergy and Clinical Immunology|October 12, 2010
Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophyWan-Fai Ng, Alexei von Delwig, Andrew J Carmichael, et al.
BMJ Open|August 23, 2014
Developing a service user informed intervention to improve participation and ability to perform daily activities in primary Sjögren's syndrome: a mixed-methods study protocolKatie L Hackett, Julia L Newton, Katherine H O Deane, et al.
Rheumatology (Oxford, England)|December 26, 2016
An investigation into the prevalence of sleep disturbances in primary Sjögren's syndrome: a systematic review of the literatureKatie L Hackett, Zoe M Gotts, Jason Ellis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Quantitating effector and regulatory T lymphocytes in immune responses by limiting dilution analysis modelingThierry Bonnefoix, Philippe Bonnefoix, Pascal Perron, et al.
Digital Biomarkers|October 30, 2023
Regulatory Qualification of a Cross-Disease Digital Measure: Benefits and Challenges from the Perspective of IMI Consortium IDEA-FASTDavid Nobbs, Wojciech Piwko, Christopher Bull, et al.
RMD Open|January 12, 2026
Spotlight on Sjögren's: a patient perspective on burden of illness and unmet needs - results from a real-world surveyJessica Marvel, Gayle Kenney, Janet Church, et al.
Pharmaceutical Statistics|June 25, 2019
Between a ROC and a hard place: Teaching prevalence plots to understand real world biomarker performance in the clinicB Clare Lendrem, Dennis W Lendrem, Arthur G Pratt, et al.
Nature Communications|January 27, 2026
Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK BiobankBastien Rioux, Sarah McGlasson, Deborah Forbes, et al.
The Lancet. Rheumatology|August 1, 2024
Digital health technologies to strengthen patient-centred outcome assessment in clinical trials in inflammatory arthritisDylan McGagh, Kaiyang Song, Hang Yuan, et al.
Rheumatology International|June 24, 2021
Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquineAlexis Collins, Dennis Lendrem, James Wason, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
The Journal of Allergy and Clinical Immunology|October 12, 2010
Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophyWan-Fai Ng, Alexei von Delwig, Andrew J Carmichael, et al.
BMJ Open|August 23, 2014
Developing a service user informed intervention to improve participation and ability to perform daily activities in primary Sjögren's syndrome: a mixed-methods study protocolKatie L Hackett, Julia L Newton, Katherine H O Deane, et al.
Rheumatology (Oxford, England)|December 26, 2016
An investigation into the prevalence of sleep disturbances in primary Sjögren's syndrome: a systematic review of the literatureKatie L Hackett, Zoe M Gotts, Jason Ellis, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 8, 2005
Quantitating effector and regulatory T lymphocytes in immune responses by limiting dilution analysis modelingThierry Bonnefoix, Philippe Bonnefoix, Pascal Perron, et al.
Digital Biomarkers|October 30, 2023
Regulatory Qualification of a Cross-Disease Digital Measure: Benefits and Challenges from the Perspective of IMI Consortium IDEA-FASTDavid Nobbs, Wojciech Piwko, Christopher Bull, et al.
RMD Open|January 12, 2026
Spotlight on Sjögren's: a patient perspective on burden of illness and unmet needs - results from a real-world surveyJessica Marvel, Gayle Kenney, Janet Church, et al.
Pharmaceutical Statistics|June 25, 2019
Between a ROC and a hard place: Teaching prevalence plots to understand real world biomarker performance in the clinicB Clare Lendrem, Dennis W Lendrem, Arthur G Pratt, et al.
Nature Communications|January 27, 2026
Oligoprotein type I interferon signatures, but not TREX1 variants, increase risk of systemic lupus erythematosus in UK BiobankBastien Rioux, Sarah McGlasson, Deborah Forbes, et al.
The Lancet. Rheumatology|August 1, 2024
Digital health technologies to strengthen patient-centred outcome assessment in clinical trials in inflammatory arthritisDylan McGagh, Kaiyang Song, Hang Yuan, et al.
Rheumatology International|June 24, 2021
Revisiting the JOQUER trial: stratification of primary Sjögren's syndrome and the clinical and interferon response to hydroxychloroquineAlexis Collins, Dennis Lendrem, James Wason, et al.
Pageof 14